BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36219563)

  • 1. The ribosomal chaperone NACA recruits PHD2 to cotranslationally modify HIF-α.
    Song D; Peng K; Palmer BE; Lee FS
    EMBO J; 2022 Nov; 41(22):e112059. PubMed ID: 36219563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing.
    Song D; Li LS; Arsenault PR; Tan Q; Bigham AW; Heaton-Johnson KJ; Master SR; Lee FS
    J Biol Chem; 2014 May; 289(21):14656-65. PubMed ID: 24711448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor.
    Arsenault PR; Song D; Bergkamp M; Ravaschiere AM; Navalsky BE; Lieberman PM; Lee FS
    Chembiochem; 2016 Dec; 17(24):2316-2323. PubMed ID: 27770548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl hydroxylase domain protein 2 (PHD2) binds a Pro-Xaa-Leu-Glu motif, linking it to the heat shock protein 90 pathway.
    Song D; Li LS; Heaton-Johnson KJ; Arsenault PR; Master SR; Lee FS
    J Biol Chem; 2013 Apr; 288(14):9662-9674. PubMed ID: 23413029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α.
    Arsenault PR; Song D; Chung YJ; Khurana TS; Lee FS
    Mol Cell Biol; 2016 Sep; 36(18):2328-43. PubMed ID: 27325674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23.
    Song D; Guan W; Coon LM; Al-Kali A; Oliveira JL; Lee FS
    Hypoxia (Auckl); 2019; 7():81-86. PubMed ID: 31853455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
    Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
    Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.
    Ladroue C; Hoogewijs D; Gad S; Carcenac R; Storti F; Barrois M; Gimenez-Roqueplo AP; Leporrier M; Casadevall N; Hermine O; Kiladjian JJ; Baruchel A; Fakhoury F; Bressac-de Paillerets B; Feunteun J; Mazure N; Pouysségur J; Wenger RH; Richard S; Gardie B
    Haematologica; 2012 Jan; 97(1):9-14. PubMed ID: 21933857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
    Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
    J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibetan
    Song D; Navalsky BE; Guan W; Ingersoll C; Wang T; Loro E; Eeles L; Matchett KB; Percy MJ; Walsby-Tickle J; McCullagh JSO; Medina RJ; Khurana TS; Bigham AW; Lappin TR; Lee FS
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12230-12238. PubMed ID: 32414920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.
    Al-Sheikh M; Moradkhani K; Lopez M; Wajcman H; Préhu C
    Blood Cells Mol Dis; 2008; 40(2):160-5. PubMed ID: 17933562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the
    Moore JA; Hubbi ME; Wang C; Wang Y; Luo W; Hofmann S; Rambally S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620947256. PubMed ID: 32755251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
    Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
    Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen sensing: recent insights from idiopathic erythrocytosis.
    Lee FS; Percy MJ; McMullin MF
    Cell Cycle; 2006 May; 5(9):941-5. PubMed ID: 16687917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.
    Albiero E; Ruggeri M; Fortuna S; Finotto S; Bernardi M; Madeo D; Rodeghiero F
    Haematologica; 2012 Jan; 97(1):123-7. PubMed ID: 21828119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
    Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
    Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
    J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
    Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
    Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
    Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
    BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.